Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics ...

today announced that it will be presenting data from its DCCR clinical development program for the treatment of Prader-Willi syndrome (PWS) at the 62nd Annual European Society for Paediatric ...

SINGAPORE - Growing teens have voracious appetites, but Teo Zi Yee, 17, and David Lucas Soo, 13, feel starved constantly and cannot be left unattended with food. They have Prader-Willi syndrome (PWS) ...

in order to raise awareness of such cases and to enhance our knowledge regarding the diagnosis and prompt treatment of this particular PWS patients. Prader-Willi syndrome (PWS, OMIM176270) is a rare ...

Katie Price stunned fans by sharing a video appearing to pick fun at an overweight man, despite having raged about 'disgusting' trolls who bully her own son Harvey ...

Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't disclose any terms in its SEC filing, but indicated in its filing fee schedule ...

Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 54.47%, which has investors questioning if this is right ...

Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.

Cystic-fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...